Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of ...

A 41-year-old man was evaluated for swelling in the ankles and syncope. CT of the chest showed bilateral mediastinal and ...

A failing left ventricle cannot accommodate the increased blood volume from the right ventricle ... could represent an adverse worsened clinical prognosis. Persistent orthopnea despite intensive ...

An artificial right heart atrium that could save the lives of children with a rare disease. An AI-powered method to prevent blindness from ...

The most common cardiovascular killer in maternal medicine is also among the most misdiagnosed. Peripartum cardiomyopathy ...

Chronic thromboembolic pulmonary hypertension occurs in a proportion of patients with prior acute pulmonary embolism and is characterised by breathlessness, persistently raised pulmonary pressures and ...

Men with PAH had a larger right heart size and worse survival than women, independent of body size and functional status, a ...

Background Early heart failure (HF ... Incident HF diagnosis was classified into inpatient or outpatient and stratified by ejection fraction (EF). A non-HF comparator group with normal left ...

Joanne Matos, 37, was born with an enlarged heart and has congestive heart failure. Despite a stroke and two silent heart ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the Phase 3 HYPERION study evaluating WINREVAIR (sotatercept-csrk) versus placebo (both in combination with ...